⌘K

Login Start Free

Home/Insiders/Tourangeau Greg

TG

SEC Insider//CIK 0001916566

Tourangeau Greg

CIK 00019165661 companyCAMBRIDGE, MA

Transactions

12

Companies

1

Filings

10

CIK

0001916566

Recent Transactions

12 trades

Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2026-02-02+57,000→ 57,000 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2025-05-08$5.06/sh−498→ 14,062 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2025-01-24+76,120→ 76,120 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2024-05-07$7.76/sh−236→ 11,571 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2024-03-08$11.72/sh−4,884→ 11,807 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2024-01-26+10,000→ 10,000 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2024-01-26+83,820→ 83,820 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2023-05-10$3.31/sh−210→ 15,992 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2023-02-09+16,100→ 16,100 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-07-15+16,540→ 16,540 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-05-06+6,500→ 6,500 total
Award
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-05-06+3,250→ 16,202 total

Companies

1

Fulcrum Therapeutics, Inc.
Principal Accounting Officer
$FULC

Recent Filings

10

Address

C/O FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET

CAMBRIDGE, MA, 02139

View on SEC.gov